[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omeros Corp (OMER)

Omeros Corp (OMER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 671,640
  • Shares Outstanding, K 72,375
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,350 K
  • EBIT $ -105 M
  • EBITDA $ -106 M
  • 60-Month Beta 2.55
  • Price/Sales 67.06
  • Price/Cash Flow 4.96
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 98.19% (+20.03%)
  • Historical Volatility 100.49%
  • IV Percentile 39%
  • IV Rank 19.66%
  • IV High 271.38% on 12/23/25
  • IV Low 55.81% on 02/13/26
  • Expected Move (DTE 11) 1.40 (13.56%)
  • Put/Call Vol Ratio 0.53
  • Today's Volume 3,293
  • Volume Avg (30-Day) 5,384
  • Put/Call OI Ratio 0.69
  • Today's Open Interest 95,758
  • Open Int (30-Day) 92,938
  • Expected Range 8.94 to 11.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.27
  • Number of Estimates 1
  • High Estimate $-0.27
  • Low Estimate $-0.27
  • Prior Year $-0.53
  • Growth Rate Est. (year over year) +49.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.70 +54.28%
on 06/12/26
10.83 -4.55%
on 06/24/26
+0.55 (+5.62%)
since 06/05/26
3-Month
6.70 +54.28%
on 06/12/26
15.32 -32.51%
on 05/01/26
-0.55 (-5.01%)
since 04/06/26
52-Week
3.00 +244.67%
on 07/07/25
17.65 -41.42%
on 12/24/25
+7.14 (+223.13%)
since 07/03/25

Most Recent Stories

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER

NEW YORK , July 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Omeros Corporation ("Omeros" or the "Company") (NASDAQ: OMER). Such investors are advised to...

OMER : 10.34 (+11.42%)
Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA

Omeros Corporation (Nasdaq: OMER) announced today an update on the review by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) of the company’s...

OMER : 10.34 (+11.42%)
Omeros Announces Webcast Details for Annual Meeting of Shareholders

Omeros Corporation (Nasdaq: OMER) today announced that the company will host a live webcast of its Annual Meeting of Shareholders, which will be held virtually on Thursday, June 18, 2026, beginning at...

OMER : 10.34 (+11.42%)
Omeros Q1 Earnings Call Highlights

Omeros (NASDAQ:OMER) reported first-quarter 2026 net income of $56.1 million, or $0.78 per share, as the company began commercial sales of YARTEMLEA, its recently approved treatment for hematopoietic stem...

OMER : 10.34 (+11.42%)
Omeros: Q1 Earnings Snapshot

Omeros: Q1 Earnings Snapshot

OMER : 10.34 (+11.42%)
Omeros Corporation Reports First Quarter 2026 Financial Results

– Conference Call Today at 4:30 p.m. ET

OMER : 10.34 (+11.42%)
Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026

Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the first quarter 2026 on Wednesday, May 13, 2026 after market close. Omeros management will host a conference...

OMER : 10.34 (+11.42%)
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

SAN MATEO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic...

SGMT : 7.74 (+1.71%)
OMER : 10.34 (+11.42%)
CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)

– Permanent, product-specific J-code facilitates efficient claims and reimbursement –

OMER : 10.34 (+11.42%)
Omeros: Q4 Earnings Snapshot

Omeros: Q4 Earnings Snapshot

OMER : 10.34 (+11.42%)

Business Summary

Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM)...

See More

Key Turning Points

3rd Resistance Point 12.06
2nd Resistance Point 11.28
1st Resistance Point 10.81
Last Price 10.34
1st Support Level 9.56
2nd Support Level 8.78
3rd Support Level 8.31

See More

52-Week High 17.65
Fibonacci 61.8% 12.05
Last Price 10.34
Fibonacci 50% 10.32
Fibonacci 38.2% 8.60
52-Week Low 3.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.